Noa Therapeutics | Ontario at BIO 2025

sfo_preprocess_html() call_user_func_array() (Line: 261) Drupal\Core\Theme\ThemeManager->render() (Line: 490) Drupal\Core\Render\Renderer->doRender() (Line: 248) Drupal\Core\Render\Renderer->render() (Line: 158) Drupal\Core\Render\MainContent\HtmlRenderer->{closure:Drupal\Core\Render\MainContent\HtmlRenderer::renderResponse():153}() (Line: 637) Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153) Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90) Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray() call_user_func() (Line: 111) Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186) Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76) Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53) Drupal\Core\StackMiddleware\Session->handle() (Line: 48) Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28) Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 32) Drupal\big_pipe\StackMiddleware\ContentLength->handle() (Line: 201) Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138) Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87) Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 48) Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51) Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36) Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51) Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741) Drupal\Core\DrupalKernel->handle() (Line: 19)

Profile

Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules, targeting barrier resolution, to effectively modify pathogenic drivers of inflammatory diseases. Adopting a systems biology and computer-assisted discovery approach, Noa is establishing a novel small molecule platform for the tailored treatment of immune diseases involving barrier dysfunction to address unmet needs in over $100B of inflammatory disease markets.